Opportunity Information: Apply for DP 10 005
Apply for DP 10 005
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Translating Research Into Action for Diabetes (TRIAD) Legacy Study (U58)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.283 Centers for Disease Control and PreventionInvestigations and Technical Assistance.
- This funding opportunity was created on Jan 12, 2010 and posted on Jan 12, 2010.
- Applicants must submit their applications by Feb 12, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $600,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $150,000.00 in funding.
- The number of recipients for this funding is limited to 6 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Only applicants who have been funded under CDC Program Announcement No. 04005 (or their successor organization), Translating Research Into Action for Diabetes (TRIAD) are eligible to compete for this funding opportunity. Competition is limited to TRIAD recipients under CDC Program Announcement No. 04005 because they are uniquely positioned to perform, oversee, coordinate, and access the unique existing TRIAD databases. These research institutions include Indiana University Diabetes Research and Training Center Kaiser Permanente Oakland, California Pacific Health Research Institute Honolulu, Hawaii (or their successor organization) University of California Los Angeles University of Medicine and Dentistry of New Jersey and University of Michigan.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Translating Research Into Action for Diabetes (TRIAD) Legacy Study (U58) was a CDC discretionary funding opportunity designed to extend the value of the long-running TRIAD research program by supporting additional analysis and dissemination of results using the existing TRIAD datasets. Rather than funding new data collection, the program focused on leveraging the unique, already-established TRIAD databases to answer remaining research questions about how health systems and patient-level factors influence long-term diabetes care and outcomes. The overarching intent was to generate actionable evidence on what drives better care processes, lowers complications and risk, improves quality of life, and affects morbidity, mortality, and costs for people living with diabetes.
Scientifically, the opportunity emphasized examining associations between health care delivery features (such as system organization, care management approaches, access and continuity, and quality improvement practices) and patient-related characteristics (such as demographics, clinical status, behaviors, and barriers to care) with key long-term endpoints. Those endpoints included processes of care over time, diabetes-related complications and other morbidity, mortality, patient-reported quality of life, and economic impacts, including costs and cost-related drivers. In practical terms, the goal was to translate the TRIAD evidence into clearer guidance for health systems, clinicians, payers, and public health partners about which strategies are most likely to reduce risk and complications and improve outcomes at scale.
A central deliverable expectation was publication and broad dissemination. Awardees were expected to produce peer-reviewed manuscripts from the TRIAD data, complete analyses tied to remaining hypotheses, and share findings beyond academic journals through additional channels such as websites and outreach to consumer, professional, and business organizations, as well as training programs. This reflects the program's emphasis on moving from research findings to real-world use, making results accessible to audiences who can implement changes in care and policy.
Mechanistically, funding was provided as a cooperative agreement (U58), meaning CDC anticipated substantial involvement beyond standard grants management, typically including collaboration on priorities, coordination, and dissemination expectations. The announcement (Funding Opportunity Number DP 10 005; CFDA 93.283) anticipated up to six awards. Total estimated funding was $600,000, with individual awards ranging from $50,000 to $150,000. There was no cost-sharing or matching requirement.
Eligibility was intentionally narrow and limited to organizations previously funded under CDC Program Announcement No. 04005 (or successor organizations) for TRIAD. The rationale was that only prior TRIAD recipients were positioned to manage, coordinate, and access the specialized TRIAD databases and to carry out analyses efficiently and responsibly. The eligible institutions listed included Indiana University Diabetes Research and Training Center; Kaiser Permanente (Oakland, California); Pacific Health Research Institute (Honolulu, Hawaii) or its successor; University of California, Los Angeles; University of Medicine and Dentistry of New Jersey; and University of Michigan.
From an administrative standpoint, the opportunity was posted January 12, 2010, with a closing date of February 12, 2010, and an archive date of March 14, 2010. Applicants needing help accessing the full announcement were directed to CDC’s procurement/grants office contact (CDC/PGOTIM) at 770-488-2700 or pgotim@cdc.gov.
TRIAD Legacy Study (U58) - FAQs
What is the Translating Research Into Action for Diabetes (TRIAD) Legacy Study (U58)?
The TRIAD Legacy Study (U58) was a CDC discretionary funding opportunity intended to extend the value of the long-running TRIAD research program. It supported additional analysis and dissemination using existing TRIAD datasets, with an emphasis on producing actionable evidence about long-term diabetes care and outcomes.
What was the main purpose of this funding opportunity?
The purpose was to leverage the already-established TRIAD databases to answer remaining research questions about how health systems and patient-level factors influence long-term diabetes care and outcomes. The overarching intent was to generate evidence that can be used in real-world settings to improve care processes, reduce complications and risk, improve quality of life, and affect morbidity, mortality, and costs for people living with diabetes.
Was this opportunity meant to fund new data collection?
No. The opportunity focused on analyzing and disseminating findings from existing TRIAD datasets rather than funding new data collection.
What kinds of research questions or analyses were emphasized?
The opportunity emphasized analyses of associations between health care delivery features and patient-related characteristics with long-term diabetes endpoints. In other words, it prioritized work that links how care is organized and delivered, and who patients are and what barriers they face, to measurable outcomes over time.
What health care delivery features were specifically highlighted?
The announcement highlighted health system and care delivery features such as system organization, care management approaches, access and continuity of care, and quality improvement practices.
What patient-level factors were specifically highlighted?
Examples of patient-related characteristics included demographics, clinical status, behaviors, and barriers to care.
What outcomes or endpoints were awardees expected to examine?
Key long-term endpoints included processes of care over time, diabetes-related complications and other morbidity, mortality, patient-reported quality of life, and economic impacts (including costs and cost-related drivers).
What was meant by "translating research into action" in this program?
In practical terms, the goal was to turn TRIAD evidence into clearer guidance for audiences that can implement changes at scale, including health systems, clinicians, payers, and public health partners. The intent was to identify strategies most likely to reduce risk and complications and improve outcomes in real-world practice and policy.
What deliverables were expected from awardees?
A central expectation was publication and broad dissemination. Awardees were expected to produce peer-reviewed manuscripts using TRIAD data, complete analyses tied to remaining hypotheses, and share findings beyond academic journals through additional dissemination channels.
What dissemination channels were mentioned besides peer-reviewed journals?
The opportunity referenced dissemination through websites and outreach to consumer, professional, and business organizations, as well as training programs.
What type of funding mechanism was used?
Funding was provided as a cooperative agreement (U58).
What does it mean that this was a cooperative agreement (U58)?
A cooperative agreement means CDC anticipated substantial involvement beyond standard grants management. This typically includes collaboration on priorities, coordination, and dissemination expectations.
What was the funding opportunity number and CFDA number?
The Funding Opportunity Number was DP 10 005, and the CFDA number was 93.283.
How many awards were anticipated?
The announcement anticipated up to six awards.
What was the total estimated funding amount?
The total estimated funding was $600,000.
What was the expected range of individual award amounts?
Individual awards were expected to range from $50,000 to $150,000.
Was cost-sharing or matching required?
No. The opportunity stated there was no cost-sharing or matching requirement.
Who was eligible to apply?
Eligibility was intentionally narrow. It was limited to organizations previously funded under CDC Program Announcement No. 04005 (or successor organizations) for TRIAD.
Why was eligibility limited to prior TRIAD recipients?
The rationale given was that only prior TRIAD recipients were positioned to manage, coordinate, and access the specialized TRIAD databases, and to carry out analyses efficiently and responsibly.
Which institutions were listed as eligible?
The eligible institutions listed were Indiana University Diabetes Research and Training Center; Kaiser Permanente (Oakland, California); Pacific Health Research Institute (Honolulu, Hawaii) or its successor; University of California, Los Angeles; University of Medicine and Dentistry of New Jersey; and University of Michigan.
When was the opportunity posted, and what were the closing and archive dates?
The opportunity was posted January 12, 2010. The closing date was February 12, 2010, and the archive date was March 14, 2010.
Who could applicants contact for help accessing the full announcement?
Applicants needing help accessing the full announcement were directed to CDC's procurement/grants office contact (CDC/PGOTIM) at 770-488-2700 or pgotim@cdc.gov.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Developing Sustainable Influenza Surveillance Networks and Response to Avian and Pandemic by National Health Authorities outside the United States
Previous opportunity: NEA Literature Fellowships Creative Writing, FY 2011
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for DP 10 005
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (DP 10 005) also looked into and applied for these:
| Funding Opportunity |
|---|
| Developing Sustainable Influenza Surveillance Networks and Response to Avian and Pandemic by National Health Authorities outside the United States Apply for CDC RFA IP10 1001 Funding Number: CDC RFA IP10 1001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Improving Availability of Safe Blood Transfusion Services in the Republic of Mali under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1091 Funding Number: CDC RFA PS10 1091 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Prevention of Sexual Transmission of HIV/AIDs in Haiti Apply for 521 10 002 Funding Number: 521 10 002 Agency: Haiti USAID Port Au Prince Category: Health Funding Amount: $18,000,000 |
| Strengthening the Capacity of the HIV/AIDS Division of the Federal Ministry of Health to Coordinate and Oversee HIV Prevention, Care and Treatment Programs and to Expand Access to High Quality and Integrated HIV Services, including Surveillance, Moni Apply for CDC RFA PS10 1055 Funding Number: CDC RFA PS10 1055 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Supporting the National Blood Transfusion Service in the Implementation and Expansion of Blood Safety Activities in Ethiopia under the President s Emergency Plan for AIDS Relief Apply for CDC RFA PS10 10111 Funding Number: CDC RFA PS10 10111 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Best Practices in Womens Health Apply for HRSA 10 152 Funding Number: HRSA 10 152 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Revitalizing Core Environmental Health Programs through the Environmental Health Specialists Network (EHS Net) Research (U01) Apply for RFA EH 10 001 Funding Number: RFA EH 10 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $175,000 |
| Strengthening Public Health Laboratory Systems in the Republic of Cameroon Apply for CDC RFA PS10 1052 Funding Number: CDC RFA PS10 1052 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $10,000,000 |
| Enhancing Quality of the Life Skills Curriculum through the Provision of Technical Expertise in the Republic of Botswana Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1092 Funding Number: CDC RFA PS10 1092 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $800,000 |
| Building Mozambican Capacity to Implement Quality HIV/AIDS Prevention, Care, and Treatment Programs in the Republic of Mozambique Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10155 Funding Number: CDC RFA PS10 10155 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Strengthening HIV Strategic Information Activities in the Republic of Senegal Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1043 Funding Number: CDC RFA PS10 1043 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Support for Private Sector HIV Care and Treatment Services in the Free State Province of the Republic of South Africa Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1047 Funding Number: CDC RFA PS10 1047 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,300,000 |
| Strengthening National Laboratory Systems towards WHO AFRO Stepwise Accreditation in the Republic of Ghana Under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1070 Funding Number: CDC RFA PS10 1070 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| National Laboratory Systems Strengthening for Equipment Maintenance and Calibration for WHO AFRO Stepwise Accreditation in the Republic of Ghana under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1071 Funding Number: CDC RFA PS10 1071 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| HIV Prevention Among High Risk Men in the Republic of Botswana under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 1093 Funding Number: CDC RFA PS10 1093 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| Building Human Resource Capacity within the Ministry of Health and Social Services in the Republic of Namibia Under PEPFAR Apply for CDC RFA PS10 1096 Funding Number: CDC RFA PS10 1096 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $12,571,454 |
| Supporting the Scale up of Combination HIV/AIDS Prevention Services for General Populations and Youth using Evidence based, Cost effective Approaches in the Republic of Kenya under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10134 Funding Number: CDC RFA PS10 10134 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| Utilizing National Data Triangulation to Inform Program Effectiveness, Identify Program Gaps and Determine Synergies Across Priority Program Areas in the Republic of Rwanda Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10137 Funding Number: CDC RFA PS10 10137 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Increasing Capacity to Implement Science Based Interventions Targeting Men Who Have Sex with Other Men in the Dominican Republic Under the President s Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA PS10 10142 Funding Number: CDC RFA PS10 10142 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $250,000 |
| NCMHD Innovative Faith Based Approaches to Health Disparities Research (R21) Apply for RFA MD 10 004 Funding Number: RFA MD 10 004 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "DP 10 005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.